相关实验视频
Updated: May 14, 2025

07:04
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
161
在固体瘤免疫疗法中出现的新型免疫检查点抑制剂
Amirhoushang Poorkhani1, Mahboubeh Tajaldini1, Farahnazsadat Ahmadi1
1Ischemic Disorder Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Naunyn-Schmiedeberg's archives of pharmacology
|April 11, 2025
概括
像TIM-3和LAG-3这样的新型免疫检查点抑制剂 (ICI) 提供了新的癌症疗法. 结合这些药物可以克服对当前治疗的耐药性,改善固体瘤的结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 针对PD-1/PD-L1和CTLA-4的免疫检查点抑制剂 (ICI) 已经改变了癌症治疗.
- 患者对当前ICI的耐药性需要开发新的治疗策略.
研究的目的:
- 审查PD-1/PD-L1和CTLA-4之外的新兴免疫检查点抑制剂 (ICI).
- 探索新的标,如T细胞免疫球蛋白和粘素域3 (TIM-3) 和淋巴细胞激活基因3 (LAG-3).
- 讨论在固体瘤中增强免疫疗法疗效的组合策略.
主要方法:
- 对新型ICI的临床前和临床数据的审查.
- 对新的检查点目标采取行动机制的分析.
- 评估正在进行的临床试验结果的疗效和安全性.
主要成果:
- 针对TIM-3,LAG-3和VISTA的新型ICI显示出对固体瘤的承诺.
- 为了克服耐药性,正在研究涉及多种ICI的组合疗法.
- 早期的试验表明新药的潜在疗效和可管理的安全性.
结论:
- 下一代ICI代表了癌症免疫疗法的重大进步.
- 组合策略是克服抵抗和改善患者反应的关键.
- 进一步的研究对于充分实现新型免疫疗法对固体瘤的治疗潜力至关重要.
相关概念视频
Tumor Immunotherapy
406
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
406
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Vaccines
260
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
260
Cytotoxic T Cells-mediated Immune Response
737
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
737

